The more the stakeholders in the clinical research enterprise can foster the “we’re all in this together” attitude, the more wins we will all chalk up as we map the way to modern trials.
Patients aren’t joining clinical trials for the small reimbursements they may receive, expert says. “They know their volunteerism can advance science and help others.”
“If our objective [as an industry] is to develop trials with populations that reflect the real world, we must include everyone—it’s a moral and scientific imperative.”
“The Latinx population [by and large] still doesn’t understand what clinical trials are, and why they are important. We must do a better job at educating them.”
The way clinical trials are structured is “really prohibitive” for underserved populations, expert says.